NIH is the largest public funder of biomedical research in the world, which also means we have a lot of funding data! To get at-a-glance graphics and tables of NIH funding trends on grant awards, you can explore the NIH Data Book.
Ten years ago, NIH launched the RePORT (Research Portfolio Online Reporting Tools) website to serve as a one-stop shop for reports, data, and analyses of NIH research activities. Well, drum roll please, a new and modernized RePORT site as well as a faster and easier to use NIH RePORTER have now arrived. The updated RePORT site strives to meet the needs of today’s users based on feedback received over the years. It is easier, simpler, and quicker to access the same information you have come to rely upon.
7 Comments
Funding decisions rely heavily on peer review scores, but there is more to the story. NIH Institutes and Centers (ICs) weigh those scores together with ensuring their entire research portfolio addresses the wide array of diseases, conditions, or other research areas within its mission. They also account for unmet scientific needs and build on recent unexpected breakthroughs as part of prudent planning. When public health needs emerge, such as for the opioid epidemic or a microbial outbreak, ICs must be nimble enough to respond. Training, work force, and infrastructure needs are also thrown into the mix.
We present FY 2018 data on R01-equivalent applications and R56-Bridge awards, showing percentiles for both funded and unfunded applications.
0 Comments
For the New Year, we resolve to make NIH data, reports, and analyses more accessible, interactive, and easy to use. For over a decade, the NIH Data Book has served as a helpful resource for describing funding trends on grants and contract awards, success rates, small business programs, peer review, as well as the scientific workforce. These data, presented as graphics and tables, have allowed you to get a better understanding of decisions made here at NIH. We are proud to announce a new edition is available for your 2019 reading list.
4 Comments
0 Comments